EL
Elutia Inc. (ELUT)
NASDAQ·Healthcare·Biotechnology
$1.02
+1.51%
Mkt Cap $49.96M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$8.88
Range $5.00 – $10.50
Implied Upside
+774.8%
Consensus $8.88 vs current $1.02
NASDAQ·Healthcare·Biotechnology
$1.02
+1.51%
Mkt Cap $49.96M
No recent rating data.
Price Target (4 analysts)
$8.88
Range $5.00 – $10.50
+774.8%
Consensus $8.88 vs current $1.02